TSS
DWTX

Two Sigma Securities’s Dogwood Therapeutics DWTX Stock Holding History

Two Sigma Securities’s Portfolio DWTX Stock Details DWTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-2,136
Closed -$9.08K – 3454
2024
Q3 		$9.08K Buy
+2,136
New +$11.1K ﹤0.01% 2607
2023
Q4 		– Sell
-904
Closed -$20.9K – 3705
2023
Q3 		$20.9K Buy
+904
New +$31.4K ﹤0.01% 2565
2023
Q1 		– Sell
-822
Closed -$4.85K – 3404
2022
Q4 		$4.85K Buy
822
+370
+82% +$2.79K ﹤0.01% 2454
2022
Q3 		$4K Buy
+452
New +$63.7K ﹤0.01% 2490

Other funds holding DWTX

UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northwestern Mutual Wealth Management
Northwestern Mutual Wealth Management Milwaukee, Wisconsin $162B AUM 16.35% 1-Year Est. Return
AWM
Activest Wealth Management Aventure, Florida $518M AUM 44.34% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.26% 1-Year Est. Return

Two Sigma Securities's DWTX Position: Q4 2024 in Review

Two Sigma Securities sold out of Dogwood Therapeutics (DWTX) in Q4 2024, closing a stake of 2,136 shares — an estimated $9.08K sold.

Two Sigma Securities first reported a position in DWTX in Q3 2022 and held it in 4 quarters. The position peaked at $20.9K in Q3 2023. 10 funds tracked by Wall St. Rank hold DWTX as of Q4 2024.

  • Two Sigma Securities reported no remaining Dogwood Therapeutics position as of Q4 2024 after selling out during the quarter.
  • Two Sigma Securities sold 2,136 Dogwood Therapeutics shares in Q4 2024, an estimated $9.08K.
  • Two Sigma Securities first reported a position in Dogwood Therapeutics in Q3 2022 and held it in 4 quarters.
  • Two Sigma Securities's Dogwood Therapeutics position peaked at $20.9K in Q3 2023.
  • 10 funds tracked by Wall St. Rank held Dogwood Therapeutics as of Q4 2024.

Based on Two Sigma Securities's 13F filing for Q4 2024, filed 14 Feb 2025.